Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pectovowen is a homeopathic combination drug (complex remedy) developed by Weber & Weber Biologische Arzneimittel for the treatment of inflammatory diseases of the respiratory tract, including acute and chronic bronchitis and associated cough. The formulation consists of six homeopathic active ingredients: Antimonium sulfuratum aurantiacum, Bryonia, Drosera, Eucalyptus globulus, Ipecacuanha, and Spongia. These components are traditionally used in homeopathy to relieve chest congestion, facilitate expectoration, and soothe spasmodic coughs. As a homeopathic preparation, its mechanism of action is based on the principle of similarity, intended to stimulate the body's self-healing processes and provide a synergistic effect to alleviate respiratory symptoms and inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pectovowen.